Summer Sale
50% off Premium Yearly
NASDAQ:SHPG
Shire PLC (SHPG)
Financials 
Technical Analysis 
(A Top Pick Feb 1/12. Up 2.18%.) Focused on special opportunities in the pharmaceutical world. Got under pressure because there were generics coming in on their key drugs but it turned out the risk wasn’t as threatening as the market had expected. Stock has been rallying lately.
Ian AinsworthIan AinsworthIan Ainsworth- «
- ‹
- 1
- ›
- »
Shire PLC (SHPG) Frequently Asked Questions
What is Shire PLC stock symbol?
Shire PLC is a American stock, trading under the symbol SHPG (previously SHPG-Q on Stockchase) on the NASDAQ (SHPG). It is usually referred to as NASDAQ:SHPG or SHPG
Is Shire PLC a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on SHPG (previously SHPG-Q on Stockchase) on Stockchase. Read the latest expert commentary for Shire PLC.
Is Shire PLC a good investment or a top pick?
Shire PLC was recommended as a Top Pick by Ian Ainsworth on 2006-01-26. Read the latest stock experts ratings for Shire PLC.
Why is Shire PLC stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Shire PLC.
Is Shire PLC worth watching?
Shire PLC is covered by Stockchase experts and is worth watching.
A pharmaceutical/biotech company. It has an extremely attractive valuation, dirt cheap, trading at under 11X forward earnings. This has a really good stable of rare disease drugs that are very much untouched in the marketplace. The pharmaceutical sector has been absolutely beaten up and is becoming absolutely compelling. Dividend yield of 0.53%. (Analysts’ price target is £6100.)